Addition of autologous mesenchymal stem cells to whole blood for bioenhanced ACL repair has no benefit in the porcine model.
about
Bridge-enhanced ACL repair: A review of the science and the pathway through FDA investigational device approvalThe Bridge-Enhanced Anterior Cruciate Ligament Repair (BEAR) Procedure: An Early Feasibility Cohort Study.Stem cell therapy: a promising biological strategy for tendon-bone healing after anterior cruciate ligament reconstruction.Anterior cruciate ligament-derived mesenchymal stromal cells have a propensity to differentiate into the ligament lineage
P2860
Addition of autologous mesenchymal stem cells to whole blood for bioenhanced ACL repair has no benefit in the porcine model.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Addition of autologous mesench ...... benefit in the porcine model.
@ast
Addition of autologous mesench ...... benefit in the porcine model.
@en
type
label
Addition of autologous mesench ...... benefit in the porcine model.
@ast
Addition of autologous mesench ...... benefit in the porcine model.
@en
prefLabel
Addition of autologous mesench ...... benefit in the porcine model.
@ast
Addition of autologous mesench ...... benefit in the porcine model.
@en
P2093
P2860
P356
P1476
Addition of autologous mesench ...... benefit in the porcine model.
@en
P2093
Benedikt L Proffen
Carla M Haslauer
Chad E Harris
Martha M Murray
Patrick Vavken
P2860
P304
P356
10.1177/0363546514559826
P577
2014-12-30T00:00:00Z